Variant report
Variant | esv19596 |
---|---|
Chromosome Location | chr8:59682320-59684458 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs186780367 | chr8:59682327-59682328 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs148474465 | chr8:59682413-59682414 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2634519 | chr8:59682414-59682415 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs190491632 | chr8:59682463-59682464 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142708002 | chr8:59682481-59682482 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181680111 | chr8:59682551-59682552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558030951 | chr8:59682554-59682555 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs145935924 | chr8:59682567-59682568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs7000903 | chr8:59682671-59682672 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
10 | rs139828905 | chr8:59682673-59682674 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs143268498 | chr8:59682735-59682736 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs146708059 | chr8:59682762-59682763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553924453 | chr8:59682784-59682785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs559499488 | chr8:59682809-59682810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs530340947 | chr8:59682837-59682838 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555499357 | chr8:59682876-59682877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140205053 | chr8:59682934-59682935 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs2726551 | chr8:59682942-59682943 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
19 | rs564787573 | chr8:59683012-59683013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs77598373 | chr8:59683054-59683055 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs33993777 | chr8:59683055-59683056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs200222854 | chr8:59683056-59683057 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs186164971 | chr8:59683066-59683067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73254320 | chr8:59683089-59683090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563497016 | chr8:59683103-59683104 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs529457741 | chr8:59683113-59683114 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs549058665 | chr8:59683165-59683166 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs565884718 | chr8:59683166-59683167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190972907 | chr8:59683168-59683169 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs150023112 | chr8:59683178-59683179 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs369819391 | chr8:59683268-59683269 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs114201955 | chr8:59683281-59683282 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs557295988 | chr8:59683301-59683302 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs573839213 | chr8:59683303-59683304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536490627 | chr8:59683310-59683311 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs145362802 | chr8:59683333-59683334 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs60119299 | chr8:59683341-59683342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs2693433 | chr8:59683356-59683357 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs71521428 | chr8:59683366-59683367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs541454468 | chr8:59683379-59683380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs182667328 | chr8:59683380-59683381 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs543435389 | chr8:59683381-59683382 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs149208459 | chr8:59683395-59683396 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2634520 | chr8:59683401-59683402 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs187625335 | chr8:59683420-59683421 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191227976 | chr8:59683438-59683439 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2634521 | chr8:59683470-59683471 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs115861016 | chr8:59683532-59683533 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs541251510 | chr8:59683543-59683544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182975859 | chr8:59683561-59683562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Melanoma | 22183965 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:59681400-59685200 | Weak transcription | Hela-S3 | cervix |
2 | chr8:59681800-59682400 | Enhancers | HUVEC | blood vessel |
3 | chr8:59682000-59689000 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr8:59682200-59687200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |